Australian Broker Call
Produced and copyrighted by at www.fnarena.com
June 29, 2022
Access Broker Call Report Archives here
COMPANIES DISCUSSED IN THIS ISSUE
Click on symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1).
Last Updated: 05:00 PM
Your daily news report on the latest recommendation, valuation, forecast and opinion changes.
This report includes concise but limited reviews of research recently published by Stockbrokers, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end.
For more info about the different terms used by stockbrokers, as well as the different methodologies behind similar sounding ratings, download our guide HERE
Today's Upgrades and Downgrades
BWX - | BWX | Downgrade to Neutral from Buy | Citi |
CIP - | Centuria Industrial REIT | Downgrade to Equal-weight from Overweight | Morgan Stanley |
CKF - | Collins Foods | Upgrade to Add from Hold | Morgans |
CLW - | Charter Hall Long WALE REIT | Downgrade to Equal-weight from Overweight | Morgan Stanley |
GPT - | GPT Group | Downgrade to Underweight from Equal-weight | Morgan Stanley |
HCW - | HealthCo Healthcare & Wellness REIT | Downgrade to Equal-weight from Overweight | Morgan Stanley |
LFG - | Liberty Financial | Downgrade to Neutral from Outperform | Credit Suisse |
NSR - | National Storage REIT | Downgrade to Underweight from Equal-weight | Morgan Stanley |
ABY ADORE BEAUTY GROUP LIMITED
Household & Personal Products
More Research Tools In Stock Analysis - click HERE
Overnight Price: $1.22
Morgan Stanley rates ABY as Overweight (1) -
Morgan Stanley reviews Australia's emerging companies in face of growing macro challenges, adopting a more conservative stance to account for higher uncertainty.
Rising interest rates and inflation are set to hit margins, and consumer demand; and growth trajectories are forecast to slow, hitting cash flows in the medium and longer term, says the broker.
Consumer-facing stocks are among the most vulnerable, says the broker, and tech stocks, particularly loss-making tech-plays, are likely to see further multiple compressions as rates rise.
Adore Beauty is one of these, and the beauty category is more competitive than the general e-commerce category.
In April, Morgan Stanley held a target price of $4. Now it stands at $1.90. But the broker retains an Overweight rating given the company is a structural growth story, leveraged to online migration, and the category is defensive, boasting high frequency purchases, which support margins and long-term unit economics.
Target price is $1.90 Current Price is $1.22 Difference: $0.68
If ABY meets the Morgan Stanley target it will return approximately 56% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 0.00 cents and EPS of 2.20 cents. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 0.00 cents and EPS of 3.70 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
AGL AGL ENERGY LIMITED
Infrastructure & Utilities
More Research Tools In Stock Analysis - click HERE
Overnight Price: $8.55
Credit Suisse rates AGL as Outperform (1) -
Credit Suisse expects AGL Energy will revise down guidance for FY22 and FY23 after the June station outages.
The broker notes that since May, the Bayswater and Liddell power stations have been performing poorly at a time of exorbitant electricity prices and expects this will cost AGL -$150m.
The company has also announced that the Loy Yang A unit2 outage will continue to mid September - an extra six weeks.
This is expected to result in a working capital outflow in the second half as the company meets higher AEMO margin requirements and the broker sharply downgrades FY22 earnings forecasts.
On the upside, electricity futures are signalling big price increases in FY24 and the broker's earnings forecasts sit sharply above downgraded consensus.
Target price rises to $10.40 from $9.30. Outperform rating retained.
Target price is $10.40 Current Price is $8.55 Difference: $1.85
If AGL meets the Credit Suisse target it will return approximately 22% (excluding dividends, fees and charges).
Current consensus price target is $9.44, suggesting upside of 12.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Credit Suisse forecasts a full year FY22 dividend of 32.00 cents and EPS of 18.96 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 34.3, implying annual growth of N/A. Current consensus DPS estimate is 24.4, implying a prospective dividend yield of 2.9%. Current consensus EPS estimate suggests the PER is 24.5. |
Forecast for FY23:
Credit Suisse forecasts a full year FY23 dividend of 35.00 cents and EPS of 49.91 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 68.6, implying annual growth of 100.0%. Current consensus DPS estimate is 49.5, implying a prospective dividend yield of 5.9%. Current consensus EPS estimate suggests the PER is 12.3. |
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
AIA AUCKLAND INTERNATIONAL AIRPORT LIMITED
Infrastructure & Utilities
More Research Tools In Stock Analysis - click HERE
Overnight Price: $6.70
Macquarie rates AIA as Outperform (1) -
Macquarie notes Auckland International Airport's near-term earnings will reflect the ongoing international passenger recovery, as airlines increase capacity and travel restrictions are rolled back. The broker anticipates international passengers will match pre-covid levels in late FY24.
The broker notes Auckland International Airport is consulting on aeronautical prices for the price setting event (PSE4). Macquarie believes the airport could lift aeronautical pricing 40% in FY24, while the likely commissioning of a new Domestic Jet terminal should also support a material lift to PSE5 pricing.
The Outperform rating is retained and the target price increases to NZ$8.57 from NZ$7.95.
Current Price is $6.70. Target price not assessed.
Current consensus price target is $7.50, suggesting upside of 13.5% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Macquarie forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 1.22 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is -0.4, implying annual growth of N/A. Current consensus DPS estimate is 0.5, implying a prospective dividend yield of 0.1%. Current consensus EPS estimate suggests the PER is N/A. |
Forecast for FY23:
Macquarie forecasts a full year FY23 dividend of 4.50 cents and EPS of 4.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 10.3, implying annual growth of N/A. Current consensus DPS estimate is 10.1, implying a prospective dividend yield of 1.5%. Current consensus EPS estimate suggests the PER is 64.2. |
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $17.92
UBS rates AMC as Buy (1) -
Despite numerous challenges for consumer packaging companies, UBS points out Amcor continues to deliver both consistent earnings and stable margins. This resilience is attributed to strong commercial management of raw materials and general cost inflation.
The analyst feels the company's premium rating versus peers is justified by a superior return on capital (ROC), balance sheet and dividend yield metrics.
Following a valuation roll forward and marking-to-market of foreign exchange exposures, the broker raises its target to $20.00 from $19.20 and retains a Buy rating.
Target price is $20.00 Current Price is $17.92 Difference: $2.08
If AMC meets the UBS target it will return approximately 12% (excluding dividends, fees and charges).
Current consensus price target is $18.46, suggesting upside of 2.5% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
UBS forecasts a full year FY22 dividend of 66.09 cents and EPS of 110.15 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 115.8, implying annual growth of N/A. Current consensus DPS estimate is 70.1, implying a prospective dividend yield of 3.9%. Current consensus EPS estimate suggests the PER is 15.6. |
Forecast for FY23:
UBS forecasts a full year FY23 dividend of 67.47 cents and EPS of 117.03 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 121.0, implying annual growth of 4.5%. Current consensus DPS estimate is 72.2, implying a prospective dividend yield of 4.0%. Current consensus EPS estimate suggests the PER is 14.9. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgan Stanley rates ARF as Equal-weight (3) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
For Arena REIT, the Equal-weight rating is retained and the target price decreases to $4.25 from $4.60. Industry view is In-Line.
Target price is $4.25 Current Price is $4.51 Difference: minus $0.26 (current price is over target).
If ARF meets the Morgan Stanley target it will return approximately minus 6% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $4.41, suggesting downside of -1.0% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 16.10 cents and EPS of 16.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 16.6, implying annual growth of -60.4%. Current consensus DPS estimate is 16.0, implying a prospective dividend yield of 3.6%. Current consensus EPS estimate suggests the PER is 26.8. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 17.10 cents and EPS of 17.20 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 17.3, implying annual growth of 4.2%. Current consensus DPS estimate is 17.1, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 25.7. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $1.30
Morgan Stanley rates AX1 as Overweight (1) -
Morgan Stanley reviews Australia's emerging companies in face of growing macro challenges, adopting a more conservative stance to account for higher uncertainty.
Rising interest rates and inflation are set to hit margins, and consumer demand; and growth trajectories are forecast to slow, hitting cash flows in the medium and longer term, says the broker.
Consumer-facing stocks are among the most vulnerable, says the broker, and tech stocks, particularly loss-making tech-plays, are likely to see further multiple compressions as rates rise.
Accent Group is one of these. In April, Morgan Stanley held a target price of $2.70. Now it stands at $1.65.
But the broker retains an Overweight rating, pointing to the company's store roll-out, its leverage to the covid reopening and structural growth profile expecting active-wear and lifestyle categories will benefit from the work-from-home theme.
Target price is $1.65 Current Price is $1.30 Difference: $0.35
If AX1 meets the Morgan Stanley target it will return approximately 27% (excluding dividends, fees and charges).
Current consensus price target is $1.49, suggesting upside of 20.0% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 4.50 cents and EPS of 7.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 9.1, implying annual growth of -36.0%. Current consensus DPS estimate is 7.7, implying a prospective dividend yield of 6.2%. Current consensus EPS estimate suggests the PER is 13.6. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 6.90 cents and EPS of 11.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 13.0, implying annual growth of 42.9%. Current consensus DPS estimate is 10.0, implying a prospective dividend yield of 8.1%. Current consensus EPS estimate suggests the PER is 9.5. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
BBN BABY BUNTING GROUP LIMITED
Apparel & Footwear
More Research Tools In Stock Analysis - click HERE
Overnight Price: $4.25
Morgan Stanley rates BBN as Overweight (1) -
Morgan Stanley reviews Australia's emerging companies in face of growing macro challenges, adopting a more conservative stance to account for higher uncertainty.
Rising interest rates and inflation are set to hit margins, and consumer demand; and growth trajectories are forecast to slow, hitting cash flows in the medium and longer term, says the broker.
Consumer-facing stocks are among the most vulnerable, says the broker, and tech stocks, particularly loss-making tech-plays, are likely to see further multiple compressions as rates rise.
Baby Bunting is one of these and while the company is well positioned to benefit from store roll-outs and possible margin improvement, weaker consumer demand is likely to weigh.
In February, Morgan Stanley held a target price of $6.90. Now, the target price is lowered to $6. Overweight rating retained.
Target price is $6.90 Current Price is $4.25 Difference: $2.65
If BBN meets the Morgan Stanley target it will return approximately 62% (excluding dividends, fees and charges).
Current consensus price target is $6.39, suggesting upside of 60.9% (ex-dividends)
The company's fiscal year ends in July.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 16.00 cents and EPS of 22.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 22.4, implying annual growth of 64.5%. Current consensus DPS estimate is 16.0, implying a prospective dividend yield of 4.0%. Current consensus EPS estimate suggests the PER is 17.7. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 18.00 cents and EPS of 25.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 26.2, implying annual growth of 17.0%. Current consensus DPS estimate is 18.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 15.2. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $42.98
Macquarie rates BHP as Outperform (1) -
BHP Group has announced details of its new social value framework, which Macquarie notes consists of six pillars across decarbonisation, environment, Indigenous partnerships, workforce, communities and supply chains.
The announcement included BHP Group's first biodiversity target, with the company aiming for at least 30% of its land and water to be operating under nature positive practices by 2030. Progress of its social value framework will be tracked by a new 2030 scorecard, including near-term milestones.
Macquarie also highlights elevated energy costs may drive momentum in the energy transition across the sector. The Outperform rating and target price of $51.00 are retained.
Target price is $51.00 Current Price is $42.98 Difference: $8.02
If BHP meets the Macquarie target it will return approximately 19% (excluding dividends, fees and charges).
Current consensus price target is $46.05, suggesting upside of 7.3% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Macquarie forecasts a full year FY22 dividend of 443.34 cents and EPS of 604.98 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 639.0, implying annual growth of N/A. Current consensus DPS estimate is 575.5, implying a prospective dividend yield of 13.4%. Current consensus EPS estimate suggests the PER is 6.7. |
Forecast for FY23:
Macquarie forecasts a full year FY23 dividend of 411.68 cents and EPS of 531.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 560.4, implying annual growth of -12.3%. Current consensus DPS estimate is 446.4, implying a prospective dividend yield of 10.4%. Current consensus EPS estimate suggests the PER is 7.7. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgan Stanley rates BWP as Underweight (5) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
Underweight rating retained for BWP Trust. The target falls to $3.60 from 3.75. Industry view: In-Line.
Target price is $3.60 Current Price is $4.13 Difference: minus $0.53 (current price is over target).
If BWP meets the Morgan Stanley target it will return approximately minus 13% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $3.70, suggesting downside of -6.7% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 18.30 cents and EPS of 17.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 17.6, implying annual growth of -57.0%. Current consensus DPS estimate is 18.2, implying a prospective dividend yield of 4.6%. Current consensus EPS estimate suggests the PER is 22.6. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 18.30 cents and EPS of 17.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 18.1, implying annual growth of 2.8%. Current consensus DPS estimate is 18.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 21.9. |
Market Sentiment: -0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $0.70
Citi rates BWX as Downgrade to Neutral from Buy (3) -
Following a FY22 guidance downgrade by BWX, Citi downgrades its rating to Neutral from Buy and slashes its target price to $0.75 from $2.76 after a change in valuation methodology.
The analyst feels a turnaround will be difficult in the face of a weakening consumer environment and inflationary pressures. It's also thought the put option for the Go-To founders is an ongoing overhang for the stock.
The broker also sees potential for disappointing revenues given BWX is less likely to invest ahead of the curve.
Target price is $0.75 Current Price is $0.70 Difference: $0.05
If BWX meets the Citi target it will return approximately 7% (excluding dividends, fees and charges).
Current consensus price target is $1.33, suggesting upside of 96.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Citi forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 3.70 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is -0.9, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is N/A. |
Forecast for FY23:
Citi forecasts a full year FY23 dividend of 0.00 cents and EPS of 7.80 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 9.2, implying annual growth of N/A. Current consensus DPS estimate is 1.0, implying a prospective dividend yield of 1.5%. Current consensus EPS estimate suggests the PER is 7.4. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates BWX as Outperform (1) -
Having decided not to sell into certain channels, BWX highlighted a strategic review of digital channels will be a priority in the next financial year. In Macquarie's opinion, BWX is sacrificing sales for working capital and the decision is likely reflective of balance sheet concerns.
The broker notes while BWX's digital channels are expected to provide $3m in sales in FY23, maintaining channels is a drag on company resources. $23.2m in capital has been raised to accelerate debt reduction, guiding to net debt of -$58-62m by June compared to the -$82m pre-capital raising.
The rating is downgraded to Neutral from Outperform and the target price decreases to $0.70 from $2.20.
Target price is $0.70 Current Price is $0.70 Difference: $0
If BWX meets the Macquarie target it will return approximately 0% (excluding dividends, fees and charges).
Current consensus price target is $1.33, suggesting upside of 96.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Macquarie forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 7.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is -0.9, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is N/A. |
Forecast for FY23:
Macquarie forecasts a full year FY23 dividend of 2.00 cents and EPS of 6.70 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 9.2, implying annual growth of N/A. Current consensus DPS estimate is 1.0, implying a prospective dividend yield of 1.5%. Current consensus EPS estimate suggests the PER is 7.4. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CAR CARSALES.COM LIMITED
Automobiles & Components
More Research Tools In Stock Analysis - click HERE
Overnight Price: $20.76
Morgans rates CAR as Hold (3) -
Carsales released a trading update broadly in-line with Morgans forecasts. Management also announced the exercise of a call option to acquire the remaining 51% of US-based Trader Interactive for around -$1.2bn, via an equity raise.
The broker likes the strategic rationale for the transaction which includes strong recent growth for Trader Interactive and the large total addressable market in US non-auto. Trader Interactive is the market leader in both RV and powersports.
While the transaction will be mid-single digit EPS accretive, the analyst points out this relies on positive tax impacts and other near-term offsetting items. The price target falls to $22.15 from $23.72. Hold.
Target price is $22.15 Current Price is $20.76 Difference: $1.39
If CAR meets the Morgans target it will return approximately 7% (excluding dividends, fees and charges).
Current consensus price target is $22.82, suggesting upside of 24.9% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgans forecasts a full year FY22 dividend of 54.00 cents and EPS of 65.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 68.7, implying annual growth of 30.5%. Current consensus DPS estimate is 53.9, implying a prospective dividend yield of 3.0%. Current consensus EPS estimate suggests the PER is 26.6. |
Forecast for FY23:
Morgans forecasts a full year FY23 dividend of 67.00 cents and EPS of 83.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 78.9, implying annual growth of 14.8%. Current consensus DPS estimate is 65.0, implying a prospective dividend yield of 3.6%. Current consensus EPS estimate suggests the PER is 23.2. |
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $11.71
Morgan Stanley rates CHC as Equal-weight (3) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
For Charter Hall, the Equal-weight rating is retained and the target price decreases to $13.45 from $15.17.
Target price is $13.45 Current Price is $11.71 Difference: $1.74
If CHC meets the Morgan Stanley target it will return approximately 15% (excluding dividends, fees and charges).
Current consensus price target is $16.98, suggesting upside of 50.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 40.20 cents and EPS of 111.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 95.5, implying annual growth of -6.7%. Current consensus DPS estimate is 33.5, implying a prospective dividend yield of 3.0%. Current consensus EPS estimate suggests the PER is 11.8. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 42.60 cents and EPS of 90.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 78.4, implying annual growth of -17.9%. Current consensus DPS estimate is 35.5, implying a prospective dividend yield of 3.2%. Current consensus EPS estimate suggests the PER is 14.4. |
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $3.03
Morgan Stanley rates CIP as Downgrade to Equal-weight from Overweight (3) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
For Centuria Industrial REIT, the rating is downgraded to Equal-weight from Overweight and the target price decreases to $3.25 from $4.35.
Target price is $3.25 Current Price is $3.03 Difference: $0.22
If CIP meets the Morgan Stanley target it will return approximately 7% (excluding dividends, fees and charges).
Current consensus price target is $3.68, suggesting upside of 29.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 17.30 cents and EPS of 18.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 18.1, implying annual growth of -84.6%. Current consensus DPS estimate is 17.2, implying a prospective dividend yield of 6.0%. Current consensus EPS estimate suggests the PER is 15.7. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 16.00 cents and EPS of 19.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 18.4, implying annual growth of 1.7%. Current consensus DPS estimate is 16.8, implying a prospective dividend yield of 5.9%. Current consensus EPS estimate suggests the PER is 15.5. |
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CKF COLLINS FOODS LIMITED
Food, Beverages & Tobacco
More Research Tools In Stock Analysis - click HERE
Overnight Price: $9.97
Macquarie rates CKF as Outperform (1) -
Collins Foods' full year result has indicated strong growth from KFC Europe, including same store sales growth of 16.8%, while KFC Australia reported minimal top line growth of 1.4% for the year.
Macquarie notes KFC Australia made some delivery market share gains as it continues to rollout Uber Eats across the store network.
The company anticipates headwind pressures will impact across the group in the near-term, with increasing costs expected to weight on margins.
The Outperform rating is retained and the target price decreases to $11.50 from $14.80.
Target price is $11.50 Current Price is $9.97 Difference: $1.53
If CKF meets the Macquarie target it will return approximately 15% (excluding dividends, fees and charges).
Current consensus price target is $11.10, suggesting upside of 10.8% (ex-dividends)
The company's fiscal year ends in May.
Forecast for FY23:
Macquarie forecasts a full year FY23 dividend of 27.60 cents and EPS of 46.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 47.0, implying annual growth of N/A. Current consensus DPS estimate is 27.8, implying a prospective dividend yield of 2.8%. Current consensus EPS estimate suggests the PER is 21.3. |
Forecast for FY24:
Macquarie forecasts a full year FY24 dividend of 31.70 cents and EPS of 52.80 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 54.6, implying annual growth of 16.2%. Current consensus DPS estimate is 31.4, implying a prospective dividend yield of 3.1%. Current consensus EPS estimate suggests the PER is 18.4. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgans rates CKF as Upgrade to Add from Hold (1) -
Morgans upgrades its rating for Collins Foods to Add from Hold after FY22 results were a 5% beat for earnings (EBITDA) compared to the prior estimate. KFC Europe was considered the standout performer, and KFC Australia also performed well.
The analyst feels the current share price represents good value. It's thought consumer demand will remain resilient and the company will utilise its pricing power to help mitigate inflation.
After applying lower peer company multiples and a higher discount rate, the broker's target price falls to $11.50 from $14.70.
Target price is $11.50 Current Price is $9.97 Difference: $1.53
If CKF meets the Morgans target it will return approximately 15% (excluding dividends, fees and charges).
Current consensus price target is $11.10, suggesting upside of 10.8% (ex-dividends)
The company's fiscal year ends in May.
Forecast for FY23:
Morgans forecasts a full year FY23 dividend of 28.00 cents and EPS of 50.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 47.0, implying annual growth of N/A. Current consensus DPS estimate is 27.8, implying a prospective dividend yield of 2.8%. Current consensus EPS estimate suggests the PER is 21.3. |
Forecast for FY24:
Morgans forecasts a full year FY24 dividend of 31.00 cents and EPS of 56.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 54.6, implying annual growth of 16.2%. Current consensus DPS estimate is 31.4, implying a prospective dividend yield of 3.1%. Current consensus EPS estimate suggests the PER is 18.4. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
UBS rates CKF as Neutral (3) -
UBS assesses a strong FY22 result and momentum into FY23 for Collins Foods though estimates short-term risk/reward is evenly balanced and retains its Neutral rating. The target price increases to $10.30 from $9.15.
The broker's margin compression concerns eased slightly following a price increase this month. Management suggests one more is likely before the end of 2022 to help partially offset further cost inflation from the poultry contract renegotiation.
Target price is $10.30 Current Price is $9.97 Difference: $0.33
If CKF meets the UBS target it will return approximately 3% (excluding dividends, fees and charges).
Current consensus price target is $11.10, suggesting upside of 10.8% (ex-dividends)
The company's fiscal year ends in May.
Forecast for FY23:
UBS forecasts a full year FY23 EPS of 45.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 47.0, implying annual growth of N/A. Current consensus DPS estimate is 27.8, implying a prospective dividend yield of 2.8%. Current consensus EPS estimate suggests the PER is 21.3. |
Forecast for FY24:
UBS forecasts a full year FY24 EPS of 55.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 54.6, implying annual growth of 16.2%. Current consensus DPS estimate is 31.4, implying a prospective dividend yield of 3.1%. Current consensus EPS estimate suggests the PER is 18.4. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $4.64
Morgan Stanley rates CLW as Downgrade to Equal-weight from Overweight (3) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
For Charter Hall Long WALE REIT, the rating is downgraded to Equal-weight from Overweight and the target price decreases to $4.65 from $5.85.
Target price is $4.65 Current Price is $4.64 Difference: $0.01
If CLW meets the Morgan Stanley target it will return approximately 0% (excluding dividends, fees and charges).
Current consensus price target is $5.04, suggesting upside of 16.7% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 30.60 cents and EPS of 30.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 30.6, implying annual growth of -73.1%. Current consensus DPS estimate is 30.6, implying a prospective dividend yield of 7.1%. Current consensus EPS estimate suggests the PER is 14.1. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 27.90 cents and EPS of 27.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 29.1, implying annual growth of -4.9%. Current consensus DPS estimate is 28.9, implying a prospective dividend yield of 6.7%. Current consensus EPS estimate suggests the PER is 14.8. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CNI CENTURIA CAPITAL GROUP
Diversified Financials
More Research Tools In Stock Analysis - click HERE
Overnight Price: $1.99
Morgan Stanley rates CNI as Overweight (1) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
For Centuria Capital, the Overweight rating is retained and the target price decreases to $2.50 from $3.45.
Target price is $2.50 Current Price is $1.99 Difference: $0.51
If CNI meets the Morgan Stanley target it will return approximately 26% (excluding dividends, fees and charges).
Current consensus price target is $2.43, suggesting upside of 27.4% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 11.00 cents and EPS of 14.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 14.9, implying annual growth of -39.3%. Current consensus DPS estimate is 11.0, implying a prospective dividend yield of 5.8%. Current consensus EPS estimate suggests the PER is 12.8. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 11.60 cents and EPS of 15.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 14.7, implying annual growth of -1.3%. Current consensus DPS estimate is 11.2, implying a prospective dividend yield of 5.9%. Current consensus EPS estimate suggests the PER is 13.0. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $0.25
Macquarie rates COE as Neutral (3) -
Cooper Energy is set to purchase Orbost Gas Plant for up to -$330m, having raised $244m in new capital. Macquarie notes while the company paid full price for the plant, the purchase should allow Cooper Energy to pursue exploration opportunities.
The company has lifted capital expenditure guidance for both the Basker Manta Gummy and Orbost's OP3D projects, while the broker also now assumes -$200m in capital expenditure to pursue exploration at Otway.
The Neutral rating is retained and the target price decreases to $0.24 from $0.26.
Target price is $0.24 Current Price is $0.25 Difference: minus $0.01 (current price is over target).
If COE meets the Macquarie target it will return approximately minus 4% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $0.28, suggesting upside of 10.4% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Macquarie forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 0.20 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is -10.7, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is N/A. |
Forecast for FY23:
Macquarie forecasts a full year FY23 dividend of 0.00 cents and EPS of 2.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 11.8, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is 2.1. |
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $1.84
Morgan Stanley rates COF as Equal-weight (3) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
For Centuria Office REIT, the Equal-weight rating is retained and the target price decreases to $1.95 from $2.30.
Target price is $1.95 Current Price is $1.84 Difference: $0.11
If COF meets the Morgan Stanley target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $2.13, suggesting upside of 23.3% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 16.60 cents and EPS of 18.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 18.2, implying annual growth of 22.3%. Current consensus DPS estimate is 16.6, implying a prospective dividend yield of 9.6%. Current consensus EPS estimate suggests the PER is 9.5. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 15.20 cents and EPS of 17.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 17.7, implying annual growth of -2.7%. Current consensus DPS estimate is 16.3, implying a prospective dividend yield of 9.4%. Current consensus EPS estimate suggests the PER is 9.8. |
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $24.45
Credit Suisse rates CPU as Outperform (1) -
Credit Suisse notes Computershare is continuing to benefit from the kick-up to its margin income from high interest rates and inflation, but says inflation comes with its own challenges outside of margins.
The broker says the underlying business benefits from low inflation and, fortunately for Computershare investors, expects inflation will return to the 3% to 4% range and help stabilise earnings (EBIT).
The broker expects the company will exceed guidance in FY22 and upgrades EPS forecasts 2% in FY22, 38% in FY23 and 34% in FY24, despite -20% downgrades to EBIT.
Outperform rating and $27 target price retained.
Target price is $27.00 Current Price is $24.45 Difference: $2.55
If CPU meets the Credit Suisse target it will return approximately 10% (excluding dividends, fees and charges).
Current consensus price target is $26.47, suggesting upside of 7.0% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Credit Suisse forecasts a full year FY22 dividend of 64.71 cents and EPS of 79.88 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 82.0, implying annual growth of N/A. Current consensus DPS estimate is 62.5, implying a prospective dividend yield of 2.5%. Current consensus EPS estimate suggests the PER is 30.2. |
Forecast for FY23:
Credit Suisse forecasts a full year FY23 dividend of 63.34 cents and EPS of 142.49 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 123.8, implying annual growth of 51.0%. Current consensus DPS estimate is 77.1, implying a prospective dividend yield of 3.1%. Current consensus EPS estimate suggests the PER is 20.0. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $4.04
Morgan Stanley rates CQR as Underweight (5) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
The rating for Charter Hall Retail REIT remains Underweight with a revised price target of $3.90, down from $4.12. Industry view is In-Line.
Target price is $3.90 Current Price is $4.04 Difference: minus $0.14 (current price is over target).
If CQR meets the Morgan Stanley target it will return approximately minus 3% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $4.19, suggesting upside of 9.0% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 24.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 28.4, implying annual growth of -44.2%. Current consensus DPS estimate is 24.6, implying a prospective dividend yield of 6.4%. Current consensus EPS estimate suggests the PER is 13.5. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 24.80 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 28.2, implying annual growth of -0.7%. Current consensus DPS estimate is 25.0, implying a prospective dividend yield of 6.5%. Current consensus EPS estimate suggests the PER is 13.6. |
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CTD CORPORATE TRAVEL MANAGEMENT LIMITED
Travel, Leisure & Tourism
More Research Tools In Stock Analysis - click HERE
Overnight Price: $18.89
Morgan Stanley rates CTD as Overweight (1) -
Morgan Stanley reviews Australia's emerging companies in the face of growing macro challenges, adopting a more conservative stance to account for higher uncertainty.
Rising interest rates and inflation are set to hit margins, and consumer demand; and growth trajectories are forecast to slow, hitting cash flows in the medium and longer term, says the broker.
Consumer-facing stocks are among the most vulnerable, says the broker, and tech stocks, particularly loss-making tech-plays, are likely to see further multiple compressions as rates rise.
Corporate Travel Management is one of these, and the broker says it has emerged leaner and more competitive and is Morgan Stanley's top reopening pick for 2022.
In May, Morgan Stanley held a target price of $30. Now it stands at $29.00. Overweight rating retained, the broker noting a more consolidated industry structure favours scale players, and the company is forecast to increase market share and benefit from lower costs.
Target price is $29.00 Current Price is $18.89 Difference: $10.11
If CTD meets the Morgan Stanley target it will return approximately 54% (excluding dividends, fees and charges).
Current consensus price target is $27.03, suggesting upside of 44.3% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 20.00 cents and EPS of 11.10 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 12.2, implying annual growth of N/A. Current consensus DPS estimate is 4.4, implying a prospective dividend yield of 0.2%. Current consensus EPS estimate suggests the PER is 153.5. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 39.00 cents and EPS of 84.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 83.6, implying annual growth of 585.2%. Current consensus DPS estimate is 30.8, implying a prospective dividend yield of 1.6%. Current consensus EPS estimate suggests the PER is 22.4. |
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgan Stanley rates DXS as Overweight (1) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
For Dexus, the Overweight rating is retained and the target price decreases to $11.20 from $12.57.
Target price is $11.20 Current Price is $9.50 Difference: $1.7
If DXS meets the Morgan Stanley target it will return approximately 18% (excluding dividends, fees and charges).
Current consensus price target is $11.03, suggesting upside of 21.5% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 53.10 cents and EPS of 69.20 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 68.3, implying annual growth of -34.9%. Current consensus DPS estimate is 53.4, implying a prospective dividend yield of 5.9%. Current consensus EPS estimate suggests the PER is 13.3. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 53.20 cents and EPS of 67.70 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 67.8, implying annual growth of -0.7%. Current consensus DPS estimate is 54.4, implying a prospective dividend yield of 6.0%. Current consensus EPS estimate suggests the PER is 13.4. |
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $2.24
Morgan Stanley rates ELO as Overweight (1) -
Morgan Stanley reviews Australia's emerging companies in the face of growing macro challenges, adopting a more conservative stance to account for higher uncertainty.
Rising interest rates and inflation are set to hit margins, and consumer demand; and growth trajectories are forecast to slow, hitting cash flows in the medium and longer term, says the broker.
Consumer-facing stocks are among the most vulnerable, says the broker, and tech stocks, particularly loss-making tech-plays, are likely to see further multiple compressions as rates rise.
Elmo Software is one of these, and the broker believes the company can scale faster than the market anticipates and enjoys stickiness and strong upselling while being insulated from global competition. The big uncertainty is cash burn.
In May, Morgan Stanley held a target price of $6.70. Now it stands at $3.50. Overweight rating retained.
Target price is $3.50 Current Price is $2.24 Difference: $1.26
If ELO meets the Morgan Stanley target it will return approximately 56% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 30.20 cents. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 23.60 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $2.58
UBS rates EVN as Buy (1) -
UBS lowers its FY23/24 production forecasts by -13 /10% for Evolution Mining following a disappointing guidance update. Forecasts for all-in sustaining costs (AISC) are also increased by 25%/5% for those same financial years.
Slower ramp-ups at Red Lake and Cowal and delays to growth at Mungari have reduced production, explains the analyst. Cost inflation has resulted from higher labour, diesel and power costs, while lower copper production from Ernest Henry has reduced copper credits.
As a result of amended forecasts, the broker's target price falls -27% to $2.95, while the Buy rating is retained.
Target price is $2.95 Current Price is $2.58 Difference: $0.37
If EVN meets the UBS target it will return approximately 14% (excluding dividends, fees and charges).
Current consensus price target is $3.39, suggesting upside of 40.7% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
UBS forecasts a full year FY22 dividend of 6.00 cents and EPS of 17.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 16.3, implying annual growth of -19.3%. Current consensus DPS estimate is 6.6, implying a prospective dividend yield of 2.7%. Current consensus EPS estimate suggests the PER is 14.8. |
Forecast for FY23:
UBS forecasts a full year FY23 dividend of 6.00 cents and EPS of 22.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 21.8, implying annual growth of 33.7%. Current consensus DPS estimate is 4.3, implying a prospective dividend yield of 1.8%. Current consensus EPS estimate suggests the PER is 11.1. |
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $18.99
Morgan Stanley rates GMG as Overweight (1) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
For Goodman Group, the Overweight rating is retained and the target price decreases to $23.70 from $25.98.
Target price is $23.70 Current Price is $18.99 Difference: $4.71
If GMG meets the Morgan Stanley target it will return approximately 25% (excluding dividends, fees and charges).
Current consensus price target is $23.86, suggesting upside of 30.5% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 30.00 cents and EPS of 80.70 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 81.2, implying annual growth of -35.2%. Current consensus DPS estimate is 30.0, implying a prospective dividend yield of 1.6%. Current consensus EPS estimate suggests the PER is 22.5. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 30.00 cents and EPS of 90.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 91.8, implying annual growth of 13.1%. Current consensus DPS estimate is 32.3, implying a prospective dividend yield of 1.8%. Current consensus EPS estimate suggests the PER is 19.9. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $4.59
Morgan Stanley rates GPT as Downgrade to Underweight from Equal-weight (5) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
Industry view is In-Line. GPT Group's rating has moved to Underweight from Equal-weight. Price target declines to $4.30 from $5.51.
Target price is $4.30 Current Price is $4.59 Difference: minus $0.29 (current price is over target).
If GPT meets the Morgan Stanley target it will return approximately minus 6% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $4.90, suggesting upside of 12.3% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 25.00 cents and EPS of 32.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 31.4, implying annual growth of -57.5%. Current consensus DPS estimate is 24.8, implying a prospective dividend yield of 5.7%. Current consensus EPS estimate suggests the PER is 13.9. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 23.80 cents and EPS of 31.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 31.8, implying annual growth of 1.3%. Current consensus DPS estimate is 25.0, implying a prospective dividend yield of 5.7%. Current consensus EPS estimate suggests the PER is 13.7. |
Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $1.54
Morgan Stanley rates HCW as Downgrade to Equal-weight from Overweight (3) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
For HealthCo Healthcare & Wellness REIT, the rating is downgraded to Equal-weight from Overweight and the target price decreases to $1.70 from $2.45.
Target price is $1.70 Current Price is $1.54 Difference: $0.16
If HCW meets the Morgan Stanley target it will return approximately 10% (excluding dividends, fees and charges).
Current consensus price target is $2.10, suggesting upside of 48.7% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 7.40 cents and EPS of 5.20 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 6.9, implying annual growth of N/A. Current consensus DPS estimate is 7.9, implying a prospective dividend yield of 5.6%. Current consensus EPS estimate suggests the PER is 20.4. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 8.50 cents and EPS of 8.10 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 8.9, implying annual growth of 29.0%. Current consensus DPS estimate is 9.0, implying a prospective dividend yield of 6.4%. Current consensus EPS estimate suggests the PER is 15.8. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
IVC INVOCARE LIMITED
Consumer Products & Services
More Research Tools In Stock Analysis - click HERE
Overnight Price: $10.69
Morgan Stanley rates IVC as Equal-weight (3) -
Morgan Stanley reviews Australia's emerging companies in the face of growing macro challenges, adopting a more conservative stance to account for higher uncertainty.
Rising interest rates and inflation are set to hit margins, and consumer demand; and growth trajectories are forecast to slow, hitting cash flows in the medium and longer term, says the broker.
Consumer-facing stocks are among the most vulnerable, says the broker, and tech stocks, particularly loss-making tech-plays, are likely to see further multiple compressions as rates rise.
Invocare is one of these. The broker appreciates the company's strong defensive profile and attractive long-term structural growth prospects. But near-term transformation risks weigh and capital expenditure is expected to drag.
In May, Morgan Stanley held a target price of $13. Now it stands at $11.25. Equal-Weight rating retained.
Target price is $11.25 Current Price is $10.69 Difference: $0.56
If IVC meets the Morgan Stanley target it will return approximately 5% (excluding dividends, fees and charges).
Current consensus price target is $12.70, suggesting upside of 20.8% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 22.00 cents and EPS of 38.10 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 38.5, implying annual growth of -31.3%. Current consensus DPS estimate is 26.6, implying a prospective dividend yield of 2.5%. Current consensus EPS estimate suggests the PER is 27.3. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 24.00 cents and EPS of 42.70 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 43.3, implying annual growth of 12.5%. Current consensus DPS estimate is 28.9, implying a prospective dividend yield of 2.7%. Current consensus EPS estimate suggests the PER is 24.3. |
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $0.20
Macquarie rates JMS as Outperform (1) -
Macquarie has described a mixed operating performance from Jupiter Mines in the first quarter, with strong production but lower shipments, while realised prices missed the broker's expectations but were largely offset by lower costs.
Manganese prices rallied in the quarter, and Macquarie notes a spot price scenario could drive 50% earnings upside.
The broker highlighted earnings from Tshipi of $58.9m were a 14% beat to forecasts, and noted consolidation potential in Tshipi and the Kalahari Manganese Fields which could be a potential catalyst for the company.
The Outperform rating and target price of $0.30 are retained.
Target price is $0.30 Current Price is $0.20 Difference: $0.1
If JMS meets the Macquarie target it will return approximately 50% (excluding dividends, fees and charges).
The company's fiscal year ends in February.
Forecast for FY23:
Macquarie forecasts a full year FY23 dividend of 3.20 cents and EPS of 4.30 cents. |
Forecast for FY24:
Macquarie forecasts a full year FY24 dividend of 2.90 cents and EPS of 3.80 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $1.05
Morgan Stanley rates KMD as Overweight (1) -
Morgan Stanley reviews Australia's emerging companies in the face of growing macro challenges, adopting a more conservative stance to account for higher uncertainty.
Rising interest rates and inflation are set to hit margins, and consumer demand; and growth trajectories are forecast to slow, hitting cash flows in the medium and longer term, says the broker.
Consumer-facing stocks are among the most vulnerable, says the broker, and tech stocks, particularly loss-making tech-plays, are likely to see further multiple compressions as rates rise.
KMD Brands is one of these, but the broker notes it is leveraged to the covid reopening and shift to outdoor activities, and appreciates the repaired balance sheet and cheap valuation.
The target price is $1.35. Overweight rating retained.
Target price is $1.35 Current Price is $1.05 Difference: $0.3
If KMD meets the Morgan Stanley target it will return approximately 29% (excluding dividends, fees and charges).
The company's fiscal year ends in July.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 5.63 cents and EPS of 5.25 cents. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 6.47 cents and EPS of 10.78 cents. |
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
LFG LIBERTY FINANCIAL GROUP LIMITED
Diversified Financials
More Research Tools In Stock Analysis - click HERE
Overnight Price: $4.30
Credit Suisse rates LFG as Downgrade to Neutral from Outperform (3) -
Credit Suisse reviews the non-bank financial sector and spies difficult times ahead as rising funding costs hit net interest margins, the outlook for credit origination blurs, and the likelihood of loan impairments rises.
The broker says the funding environment has deteriorated faster than expected and that loan growth forecasts are also weakening as higher interest rates and lower property prices come to bear.
Liberty Financial's EPS forecasts are downgraded -4% in FY22, -28% for FY23 and -29% for FY24, but the broker says value remains and recognises risks are already amply priced in to the current share price.
Rating downgraded to Neutral from Outperform. Target price cut to $4.55 from $7.
Target price is $4.55 Current Price is $4.30 Difference: $0.25
If LFG meets the Credit Suisse target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $5.60, suggesting upside of 39.7% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Credit Suisse forecasts a full year FY22 dividend of 44.00 cents and EPS of 77.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 74.1, implying annual growth of 21.0%. Current consensus DPS estimate is 44.6, implying a prospective dividend yield of 11.1%. Current consensus EPS estimate suggests the PER is 5.4. |
Forecast for FY23:
Credit Suisse forecasts a full year FY23 dividend of 34.00 cents and EPS of 61.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 66.5, implying annual growth of -10.3%. Current consensus DPS estimate is 41.4, implying a prospective dividend yield of 10.3%. Current consensus EPS estimate suggests the PER is 6.0. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $9.32
Morgan Stanley rates LLC as Equal-weight (3) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
For Lendlease Group, the Equal-weight rating is retained and the target price decreases to $11.20 from $11.40.
Target price is $11.20 Current Price is $9.32 Difference: $1.88
If LLC meets the Morgan Stanley target it will return approximately 20% (excluding dividends, fees and charges).
Current consensus price target is $12.49, suggesting upside of 34.0% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 19.80 cents and EPS of 39.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 38.1, implying annual growth of 17.2%. Current consensus DPS estimate is 19.0, implying a prospective dividend yield of 2.0%. Current consensus EPS estimate suggests the PER is 24.5. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 34.00 cents and EPS of 68.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 58.9, implying annual growth of 54.6%. Current consensus DPS estimate is 29.6, implying a prospective dividend yield of 3.2%. Current consensus EPS estimate suggests the PER is 15.8. |
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $2.12
Morgan Stanley rates MGR as Equal-weight (3) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
For Mirvac Group, the Equal-weight rating is retained and the target price decreases to $2.30 from $2.60.
Target price is $2.30 Current Price is $2.12 Difference: $0.18
If MGR meets the Morgan Stanley target it will return approximately 8% (excluding dividends, fees and charges).
Current consensus price target is $2.61, suggesting upside of 28.6% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 10.20 cents and EPS of 15.10 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 14.3, implying annual growth of -37.5%. Current consensus DPS estimate is 10.1, implying a prospective dividend yield of 5.0%. Current consensus EPS estimate suggests the PER is 14.2. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 10.40 cents and EPS of 15.10 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 15.0, implying annual growth of 4.9%. Current consensus DPS estimate is 10.8, implying a prospective dividend yield of 5.3%. Current consensus EPS estimate suggests the PER is 13.5. |
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
MMS MCMILLAN SHAKESPEARE LIMITED
Vehicle Leasing & Salary Packaging
More Research Tools In Stock Analysis - click HERE
Overnight Price: $9.74
Morgan Stanley rates MMS as Overweight (1) -
Morgan Stanley reviews Australia's emerging companies in the face of growing macro challenges, adopting a more conservative stance to account for higher uncertainty.
Rising interest rates and inflation are set to hit margins, and consumer demand; and growth trajectories are forecast to slow, hitting cash flows in the medium and longer term, says the broker.
Consumer-facing stocks are among the most vulnerable, says the broker, and tech stocks, particularly loss-making tech-plays, are likely to see further multiple compressions as rates rise.
McMillan Shakespeare is one of these, and the broker appreciates the company's undemanding valuation, stable core business and potential for structural growth and greater operating leverage.
In February, Morgan Stanley held a target price of $14. Now it stands at $12.50. Overweight rating retained.
Target price is $12.50 Current Price is $9.74 Difference: $2.76
If MMS meets the Morgan Stanley target it will return approximately 28% (excluding dividends, fees and charges).
Current consensus price target is $13.11, suggesting upside of 36.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 60.90 cents and EPS of 87.70 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 99.9, implying annual growth of 26.6%. Current consensus DPS estimate is 66.3, implying a prospective dividend yield of 6.9%. Current consensus EPS estimate suggests the PER is 9.6. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 61.10 cents and EPS of 100.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 107.3, implying annual growth of 7.4%. Current consensus DPS estimate is 68.3, implying a prospective dividend yield of 7.1%. Current consensus EPS estimate suggests the PER is 9.0. |
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $2.32
Morgan Stanley rates NSR as Downgrade to Underweight from Equal-weight (5) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
National Storage REIT has been downgraded to Underweight from Equal-weight with a revised price target of $2.15 from $2.50. Industry view is In-Line.
Target price is $2.15 Current Price is $2.32 Difference: minus $0.17 (current price is over target).
If NSR meets the Morgan Stanley target it will return approximately minus 7% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $2.37, suggesting upside of 8.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 9.50 cents and EPS of 10.10 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 10.1, implying annual growth of -66.7%. Current consensus DPS estimate is 9.7, implying a prospective dividend yield of 4.4%. Current consensus EPS estimate suggests the PER is 21.6. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 8.80 cents and EPS of 9.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 10.2, implying annual growth of 1.0%. Current consensus DPS estimate is 9.6, implying a prospective dividend yield of 4.4%. Current consensus EPS estimate suggests the PER is 21.4. |
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
NST NORTHERN STAR RESOURCES LIMITED
Gold & Silver
More Research Tools In Stock Analysis - click HERE
Overnight Price: $7.45
Citi rates NST as Buy (1) -
Citi runs the numbers on Northern Star Resources' mill expansion study (cost -$1bn) at KCGM and agrees the expansion can be funded from cash, while the dividend policy is maintained.
The company remains the broker's top pick in the Gold sector on expectations of over 10% in free cash flow for the next few years. However, cost forecasts have been raised for next year and the target price slips to $11.60 from $12.10.
Target price is $11.60 Current Price is $7.45 Difference: $4.15
If NST meets the Citi target it will return approximately 56% (excluding dividends, fees and charges).
Current consensus price target is $11.39, suggesting upside of 62.0% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Citi forecasts a full year FY22 dividend of 25.00 cents and EPS of 23.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 26.3, implying annual growth of -77.1%. Current consensus DPS estimate is 22.8, implying a prospective dividend yield of 3.2%. Current consensus EPS estimate suggests the PER is 26.7. |
Forecast for FY23:
Citi forecasts a full year FY23 dividend of 25.00 cents and EPS of 25.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 42.5, implying annual growth of 61.6%. Current consensus DPS estimate is 26.8, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 16.5. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Credit Suisse rates NST as Outperform (1) -
Northern Star Resources' findings on its KCGM mill expansion reveals a preference for the 24Mtpa option, which aligns fairly well with Credit Suisse's forecast for a 22Mtpa expansion.
However, capital expenditure forecasts and an expected delay in the build lead to downgrades in the internal rate of return.
Target price falls to $11 from $11.50. Outperform rating retained.
Target price is $11.00 Current Price is $7.45 Difference: $3.55
If NST meets the Credit Suisse target it will return approximately 48% (excluding dividends, fees and charges).
Current consensus price target is $11.39, suggesting upside of 62.0% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Credit Suisse forecasts a full year FY22 dividend of 23.00 cents and EPS of 27.12 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 26.3, implying annual growth of -77.1%. Current consensus DPS estimate is 22.8, implying a prospective dividend yield of 3.2%. Current consensus EPS estimate suggests the PER is 26.7. |
Forecast for FY23:
Credit Suisse forecasts a full year FY23 dividend of 20.00 cents and EPS of 48.38 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 42.5, implying annual growth of 61.6%. Current consensus DPS estimate is 26.8, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 16.5. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates NST as Outperform (1) -
Northern Star Resources has revealed three expansion options for the Super Pit that Macquarie notes could see production lift by as much as 200,000 ounces per annum.
The three options would see the mill capacity lift from a current 13m tonnes per annum capacity to 17m tonnes, 22m tonnes or 24m tonnes. Development of a new plant would facilitates the lift to 22m tonnes capacity, with both other options involving expansion of the existing facility.
Capital requirements range from $400-1,400m, but Macquarie expects expansion facilitating the largest capacity increase to be most likely, with this option likely to require $1,000m ($1bn) in capital.
The Outperform rating and target price of $11.00 are retained.
Target price is $11.00 Current Price is $7.45 Difference: $3.55
If NST meets the Macquarie target it will return approximately 48% (excluding dividends, fees and charges).
Current consensus price target is $11.39, suggesting upside of 62.0% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Macquarie forecasts a full year FY22 dividend of 20.70 cents and EPS of 19.10 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 26.3, implying annual growth of -77.1%. Current consensus DPS estimate is 22.8, implying a prospective dividend yield of 3.2%. Current consensus EPS estimate suggests the PER is 26.7. |
Forecast for FY23:
Macquarie forecasts a full year FY23 dividend of 29.60 cents and EPS of 44.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 42.5, implying annual growth of 61.6%. Current consensus DPS estimate is 26.8, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 16.5. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $5.93
Credit Suisse rates ORG as Neutral (3) -
Credit Suisse expects earnings (EBITDA) for energy markets will fall at the bottom end of consensus after the June scandal.
The broker estimates Origin Energy's short coal/electricity position would have cost it -$61m, compares to the more normal Eraring operation, but given the coal shortage was public knowledge at the time of the last update, estimates that at least half of this has been incorporated into guidance.
On the upside, the broker expects FY24 will improve. The broker reduces FY22 estimates, and increases FY24 earnings (EBITDA) forecasts by 10%.
Target price rises to $6.30 from $6.10. Neutral rating retained.
Target price is $6.30 Current Price is $5.93 Difference: $0.37
If ORG meets the Credit Suisse target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $6.54, suggesting upside of 10.0% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Credit Suisse forecasts a full year FY22 dividend of 25.00 cents and EPS of 29.48 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 29.1, implying annual growth of N/A. Current consensus DPS estimate is 29.6, implying a prospective dividend yield of 5.0%. Current consensus EPS estimate suggests the PER is 20.4. |
Forecast for FY23:
Credit Suisse forecasts a full year FY23 dividend of 50.00 cents and EPS of 54.16 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 41.8, implying annual growth of 43.6%. Current consensus DPS estimate is 37.3, implying a prospective dividend yield of 6.3%. Current consensus EPS estimate suggests the PER is 14.2. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
PPM PEPPER MONEY LIMITED
Business & Consumer Credit
More Research Tools In Stock Analysis - click HERE
Overnight Price: $1.32
Credit Suisse rates PPM as Outperform (1) -
Credit Suisse reviews the non-bank financial sector and spies difficult times ahead as rising funding costs hit net interest margins, the outlook for credit origination blurs, and the likelihood of loan impairments rises.
The broker says the funding environment has deteriorated faster than expected and that loan growth forecasts are also weakening as higher interest rates and lower property prices come to bear.
Pepper Money's EPS forecasts are downgraded -21% in 2022, -33% for FY23 and -31% for FY24.
The broker recognises the above risks are already amply priced in to the current share price and that the valuation discount is sufficiently compelling to warrant a positive investment stance.
Outperform rating retained. Target price cut to $1.85 from $2.95.
Target price is $1.85 Current Price is $1.32 Difference: $0.53
If PPM meets the Credit Suisse target it will return approximately 40% (excluding dividends, fees and charges).
The company's fiscal year ends in December.
Forecast for FY22:
Credit Suisse forecasts a full year FY22 dividend of 10.00 cents and EPS of 28.00 cents. |
Forecast for FY23:
Credit Suisse forecasts a full year FY23 dividend of 9.00 cents and EPS of 26.00 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
PWR PETER WARREN AUTOMOTIVE HOLDINGS LIMITED
Automobiles & Components
More Research Tools In Stock Analysis - click HERE
Overnight Price: $2.20
Morgan Stanley rates PWR as Overweight (1) -
Morgan Stanley reviews Australia's emerging companies in the face of growing macro challenges, adopting a more conservative stance to account for higher uncertainty.
Rising interest rates and inflation are set to hit margins, and consumer demand; and growth trajectories are forecast to slow, hitting cash flows in the medium and longer term, says the broker.
Consumer-facing stocks are among the most vulnerable, says the broker, and tech stocks, particularly loss-making tech-plays, are likely to see further multiple compressions as rates rise.
Peter Warren Automotive is one of these, and the broker admires its organic growth profile coupled with strategic and inorganic tailwinds.
In February, Morgan Stanley held a target price of $4.20. Now it stands at $2.90. Overweight rating retained but the broker is keeping an eye peeled to rising inflation, rates and other macro challenges.
Target price is $2.90 Current Price is $2.20 Difference: $0.7
If PWR meets the Morgan Stanley target it will return approximately 32% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 EPS of 30.90 cents. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 EPS of 28.80 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $0.92
Morgan Stanley rates RBL as Equal-weight (3) -
Morgan Stanley reviews Australia's emerging companies in the face of growing macro challenges, adopting a more conservative stance to account for higher uncertainty.
Rising interest rates and inflation are set to hit margins, and consumer demand; and growth trajectories are forecast to slow, hitting cash flows in the medium and longer term, says the broker.
Consumer-facing stocks are among the most vulnerable, says the broker, and tech stocks, particularly loss-making tech-plays, are likely to see further multiple compressions as rates rise.
Redbubble is one of these. The broker admires the valuation, balance sheet and prospects, but notes pressures are mounting.
In May, Morgan Stanley held a target price of $1.30. Now it stands at $1.00. Equal-Weight rating retained, the broker awaiting further clarity on costs.
Target price is $1.00 Current Price is $0.92 Difference: $0.08
If RBL meets the Morgan Stanley target it will return approximately 9% (excluding dividends, fees and charges).
Current consensus price target is $1.50, suggesting upside of 66.7% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 6.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is -7.8, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is N/A. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 3.20 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is -4.9, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is N/A. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgan Stanley rates SCG as Equal-weight (3) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
For Scentre Group, the Equal-weight rating is retained and the target price decreases to $2.90 from $3.18.
Target price is $2.90 Current Price is $2.73 Difference: $0.17
If SCG meets the Morgan Stanley target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $2.93, suggesting upside of 8.1% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 15.10 cents and EPS of 20.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 19.2, implying annual growth of 12.1%. Current consensus DPS estimate is 15.0, implying a prospective dividend yield of 5.5%. Current consensus EPS estimate suggests the PER is 14.1. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 15.10 cents and EPS of 21.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 20.4, implying annual growth of 6.2%. Current consensus DPS estimate is 15.8, implying a prospective dividend yield of 5.8%. Current consensus EPS estimate suggests the PER is 13.3. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
SCP SHOPPING CENTRES AUSTRALASIA PROPERTY GROUP RE LIMITED
REITs
More Research Tools In Stock Analysis - click HERE
Overnight Price: $2.93
Morgan Stanley rates SCP as Equal-weight (3) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
For Shopping Centres Australasia, the Equal-weight rating is retained and the target price decreases to $2.75 from $3.10.
Target price is $2.75 Current Price is $2.93 Difference: minus $0.18 (current price is over target).
If SCP meets the Morgan Stanley target it will return approximately minus 6% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $2.88, suggesting upside of 3.7% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 10.20 cents and EPS of 15.10 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 16.5, implying annual growth of -61.6%. Current consensus DPS estimate is 14.1, implying a prospective dividend yield of 5.1%. Current consensus EPS estimate suggests the PER is 16.8. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 10.40 cents and EPS of 15.70 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 17.2, implying annual growth of 4.2%. Current consensus DPS estimate is 14.0, implying a prospective dividend yield of 5.0%. Current consensus EPS estimate suggests the PER is 16.2. |
Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $3.94
Morgan Stanley rates SGP as Overweight (1) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
For Stockland, the Overweight rating is retained and the target price decreases to $4.75 from $5.05.
Target price is $4.75 Current Price is $3.94 Difference: $0.81
If SGP meets the Morgan Stanley target it will return approximately 21% (excluding dividends, fees and charges).
Current consensus price target is $4.63, suggesting upside of 25.4% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 26.60 cents and EPS of 35.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 32.4, implying annual growth of -30.1%. Current consensus DPS estimate is 27.0, implying a prospective dividend yield of 7.3%. Current consensus EPS estimate suggests the PER is 11.4. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 29.00 cents and EPS of 38.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 35.8, implying annual growth of 10.5%. Current consensus DPS estimate is 28.9, implying a prospective dividend yield of 7.8%. Current consensus EPS estimate suggests the PER is 10.3. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $1.08
Credit Suisse rates TAH as Outperform (1) -
Credit Suisse believes Tabcorp is well-positioned in the event of an industry restructure, noting that the company's lowest margin business is in Victoria, and about 80% of the Victorian wagering revenue is sourced digitally.
This places the company in a strong position heading into renegotiation of its Victorian licence, which expires in August 2024, says the broker, given push comes to shove, it can migrate 80% of its Victorian revenue to a lower cost jurisdiction (not 60% as the broker previously believed).
Meanwhile, wagering and media revenue are meeting second-half forecasts; a new app is forthcoming that streamlines regulatory approvals; and the media and international business is a sustainable, high margin operation, posits the broker.
FY22 EPS forecasts are lowered. Outperform rating and $1.30 target price retained.
Target price is $1.30 Current Price is $1.08 Difference: $0.22
If TAH meets the Credit Suisse target it will return approximately 20% (excluding dividends, fees and charges).
Current consensus price target is $1.12, suggesting upside of 2.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Credit Suisse forecasts a full year FY22 dividend of 12.50 cents and EPS of 0.99 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 4.8, implying annual growth of -61.0%. Current consensus DPS estimate is 11.4, implying a prospective dividend yield of 10.5%. Current consensus EPS estimate suggests the PER is 22.7. |
Forecast for FY23:
Credit Suisse forecasts a full year FY23 dividend of 2.00 cents and EPS of 3.31 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 2.8, implying annual growth of -41.7%. Current consensus DPS estimate is 2.0, implying a prospective dividend yield of 1.8%. Current consensus EPS estimate suggests the PER is 38.9. |
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates TAH as Neutral (3) -
Tabcorp Holdings has provided further detail around strategy post-demerger, with Macquarie noting the company looks to become more competitive with a new wagering app, with Tabcorp targeting a launch before the September Spring Racing carnival.
The broker also expects wagering regulatory reforms will benefit Tabcorp. Reforms should gradually address the 23% premium Tabcorp pays in taxes, agency and industry fees above corporate bookmakers.
The Outperform rating is retained and the target price increases to $1.20 from $1.05.
Target price is $1.20 Current Price is $1.08 Difference: $0.12
If TAH meets the Macquarie target it will return approximately 11% (excluding dividends, fees and charges).
Current consensus price target is $1.12, suggesting upside of 2.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Macquarie forecasts a full year FY22 dividend of 13.00 cents and EPS of 17.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 4.8, implying annual growth of -61.0%. Current consensus DPS estimate is 11.4, implying a prospective dividend yield of 10.5%. Current consensus EPS estimate suggests the PER is 22.7. |
Forecast for FY23:
Macquarie forecasts a full year FY23 dividend of 2.00 cents and EPS of 3.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 2.8, implying annual growth of -41.7%. Current consensus DPS estimate is 2.0, implying a prospective dividend yield of 1.8%. Current consensus EPS estimate suggests the PER is 38.9. |
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Ord Minnett rates TAH as Hold (3) -
Following Tabcorp's investor day, Ord Minnett maintains its Hold rating and notes a lot needs to go right for the business. This view is based upon CEO Adam Rytenskild comments regarding the company operating in the most competitive industry in Australia.
News Corp's ((NWS)) upcoming entry into the Australian market is sure to increase competition, notes the analyst. More positively, it's thought Tabcorp may gain customers if smaller bookmakers begin consolidation.
The target price is increased to $1.15 from $1.10.
This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.
Target price is $1.15 Current Price is $1.08 Difference: $0.07
If TAH meets the Ord Minnett target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $1.12, suggesting upside of 2.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Ord Minnett forecasts a full year FY22 EPS of 2.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 4.8, implying annual growth of -61.0%. Current consensus DPS estimate is 11.4, implying a prospective dividend yield of 10.5%. Current consensus EPS estimate suggests the PER is 22.7. |
Forecast for FY23:
Ord Minnett forecasts a full year FY23 EPS of 1.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 2.8, implying annual growth of -41.7%. Current consensus DPS estimate is 2.0, implying a prospective dividend yield of 1.8%. Current consensus EPS estimate suggests the PER is 38.9. |
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $4.61
UBS rates TGR as Buy (1) -
Cooke Inc. has made another non-binding indicative bid for Tassal Group at $4.85/share following prior bids at $4.67 and $4.80.
The Tassal Group board refuses to engage believing the proposal does not reflect the fundamental value of the business.
UBS maintains its Buy rating and $4.10 price target sustained by an improved outlook for pricing and cash flow.
Target price is $4.10 Current Price is $4.61 Difference: minus $0.51 (current price is over target).
If TGR meets the UBS target it will return approximately minus 11% (excluding dividends, fees and charges - negative figures indicate an expected loss).
The company's fiscal year ends in June.
Forecast for FY22:
UBS forecasts a full year FY22 EPS of 28.00 cents. |
Forecast for FY23:
UBS forecasts a full year FY23 EPS of 32.00 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
TRS REJECT SHOP LIMITED
Household & Personal Products
More Research Tools In Stock Analysis - click HERE
Overnight Price: $3.53
Morgan Stanley rates TRS as Overweight (1) -
Morgan Stanley reviews Australia's emerging companies in the face of growing macro challenges, adopting a more conservative stance to account for higher uncertainty.
Rising interest rates and inflation are set to hit margins, and consumer demand; and growth trajectories are forecast to slow, hitting cash flows in the medium and longer term, says the broker.
Consumer-facing stocks are among the most vulnerable, says the broker, and tech stocks, particularly loss-making tech-plays, are likely to see further multiple compressions as rates rise.
Reject Shop is one of these, and the broker is factoring in slower margin acceleration as inflation bites.
In June, Morgan Stanley held a target price of $9.50. Now it stands at $5. Overweight rating retained. The broker acknowledges the risk but perceives the company to be a leader in a fragmented, attractive market, the dollar-store niche outperforming globally.
Target price is $5.00 Current Price is $3.53 Difference: $1.47
If TRS meets the Morgan Stanley target it will return approximately 42% (excluding dividends, fees and charges).
Current consensus price target is $5.17, suggesting upside of 49.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 0.00 cents and EPS of 7.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 9.6, implying annual growth of -55.8%. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is 35.9. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 15.40 cents and EPS of 25.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 21.4, implying annual growth of 122.9%. Current consensus DPS estimate is 9.1, implying a prospective dividend yield of 2.6%. Current consensus EPS estimate suggests the PER is 16.1. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $1.19
Morgan Stanley rates TUA as Overweight (1) -
Morgan Stanley reviews Australia's emerging companies in the face of growing macro challenges, adopting a more conservative stance to account for higher uncertainty.
Rising interest rates and inflation are set to hit margins, and consumer demand; and growth trajectories are forecast to slow, hitting cash flows in the medium and longer term, says the broker.
Consumer-facing stocks are among the most vulnerable, says the broker, and tech stocks, particularly loss-making tech-plays, are likely to see further multiple compressions as rates rise.
Tuas is one of these. The broker admires the company's disruptive nature, strong profitability and stellar margins.
In March, Morgan Stanley held a target price of $2.20. Now it stands at $1.65. Overweight rating retained.
Target price is $1.65 Current Price is $1.19 Difference: $0.46
If TUA meets the Morgan Stanley target it will return approximately 39% (excluding dividends, fees and charges).
The company's fiscal year ends in July.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 5.70 cents. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 4.40 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $1.92
Morgan Stanley rates VCX as Underweight (5) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
For Vicinity Centres, the Underweight rating is retained and the target price decreases to $1.80 from $1.82.
Target price is $1.80 Current Price is $1.92 Difference: minus $0.12 (current price is over target).
If VCX meets the Morgan Stanley target it will return approximately minus 6% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $1.90, suggesting downside of -1.5% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 9.90 cents and EPS of 12.70 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 11.7, implying annual growth of N/A. Current consensus DPS estimate is 9.8, implying a prospective dividend yield of 5.1%. Current consensus EPS estimate suggests the PER is 16.5. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 11.20 cents and EPS of 13.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 12.5, implying annual growth of 6.8%. Current consensus DPS estimate is 10.6, implying a prospective dividend yield of 5.5%. Current consensus EPS estimate suggests the PER is 15.4. |
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $2.42
Morgan Stanley rates WPR as Underweight (5) -
Morgan Stanley expects increasing interest rates and costs of interest rate hedging will drive increased costs across its Australian property coverage.
The broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage, with stocks with higher existing debt being less impacted.
Industry view is In-Line. Waypoint REIT remains on Underweight. Price target falls to $2.20 from $2.70.
Target price is $2.20 Current Price is $2.42 Difference: minus $0.22 (current price is over target).
If WPR meets the Morgan Stanley target it will return approximately minus 9% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $2.76, suggesting upside of 17.8% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 16.20 cents and EPS of 16.20 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 16.2, implying annual growth of -71.7%. Current consensus DPS estimate is 16.5, implying a prospective dividend yield of 7.1%. Current consensus EPS estimate suggests the PER is 14.4. |
Forecast for FY23:
Morgan Stanley forecasts a full year FY23 dividend of 16.00 cents and EPS of 16.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 16.4, implying annual growth of 1.2%. Current consensus DPS estimate is 16.6, implying a prospective dividend yield of 7.1%. Current consensus EPS estimate suggests the PER is 14.3. |
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Today's Price Target Changes
Company | Last Price | Broker | New Target | Prev Target | Change | |
ABY | Adore Beauty | $1.18 | Morgan Stanley | 1.90 | 4.00 | -52.50% |
AGL | AGL Energy | $8.42 | Credit Suisse | 10.40 | 9.30 | 11.83% |
AMC | Amcor | $18.02 | UBS | 20.00 | 19.20 | 4.17% |
ARF | Arena REIT | $4.45 | Morgan Stanley | 4.25 | 4.18 | 1.67% |
AX1 | Accent Group | $1.24 | Morgan Stanley | 1.65 | 2.70 | -38.89% |
BWP | BWP Trust | $3.97 | Morgan Stanley | 3.60 | 3.65 | -1.37% |
BWX | BWX | $0.68 | Citi | 0.75 | 2.76 | -72.83% |
Macquarie | 0.70 | 2.20 | -68.18% | |||
CAR | Carsales | $18.27 | Morgans | 22.15 | 23.72 | -6.62% |
CHC | Charter Hall | $11.26 | Morgan Stanley | 13.45 | 15.17 | -11.34% |
CIP | Centuria Industrial REIT | $2.85 | Morgan Stanley | 3.25 | 4.35 | -25.29% |
CKF | Collins Foods | $10.02 | Macquarie | 11.50 | 14.80 | -22.30% |
Morgans | 11.50 | 14.70 | -21.77% | |||
UBS | 10.30 | 9.15 | 12.57% | |||
CLW | Charter Hall Long WALE REIT | $4.32 | Morgan Stanley | 4.65 | 5.85 | -20.51% |
CNI | Centuria Capital | $1.91 | Morgan Stanley | 2.50 | 3.45 | -27.54% |
COE | Cooper Energy | $0.25 | Macquarie | 0.24 | 0.26 | -7.69% |
COF | Centuria Office REIT | $1.73 | Morgan Stanley | 1.95 | 2.30 | -15.22% |
CQR | Charter Hall Retail REIT | $3.84 | Morgan Stanley | 3.90 | 4.12 | -5.34% |
CTD | Corporate Travel Management | $18.73 | Morgan Stanley | 29.00 | 30.00 | -3.33% |
DXS | Dexus | $9.08 | Morgan Stanley | 11.20 | 12.57 | -10.90% |
ELO | Elmo Software | $2.30 | Morgan Stanley | 3.50 | 6.70 | -47.76% |
EVN | Evolution Mining | $2.41 | UBS | 2.95 | 4.05 | -27.16% |
GMG | Goodman Group | $18.28 | Morgan Stanley | 23.70 | 25.98 | -8.78% |
GPT | GPT Group | $4.36 | Morgan Stanley | 4.30 | 5.51 | -21.96% |
HCW | HealthCo Healthcare & Wellness REIT | $1.41 | Morgan Stanley | 1.70 | 2.45 | -30.61% |
IVC | InvoCare | $10.51 | Morgan Stanley | 11.25 | 13.00 | -13.46% |
KMD | KMD Brands | $1.00 | Morgan Stanley | 1.35 | 1.80 | -25.00% |
LFG | Liberty Financial | $4.01 | Credit Suisse | 4.55 | 7.00 | -35.00% |
LLC | Lendlease Group | $9.32 | Morgan Stanley | 11.20 | 11.40 | -1.75% |
MGR | Mirvac Group | $2.03 | Morgan Stanley | 2.30 | 2.60 | -11.54% |
MMS | McMillan Shakespeare | $9.63 | Morgan Stanley | 12.50 | 14.30 | -12.59% |
NSR | National Storage REIT | $2.18 | Morgan Stanley | 2.15 | 2.44 | -11.89% |
NST | Northern Star Resources | $7.03 | Citi | 11.60 | 13.00 | -10.77% |
Credit Suisse | 11.00 | 11.50 | -4.35% | |||
ORG | Origin Energy | $5.94 | Credit Suisse | 6.30 | 6.10 | 3.28% |
PPM | Pepper Money | $1.23 | Credit Suisse | 1.85 | 2.95 | -37.29% |
PWR | Peter Warren Automotive | $2.13 | Morgan Stanley | 2.90 | 4.20 | -30.95% |
RBL | Redbubble | $0.90 | Morgan Stanley | 1.00 | 1.30 | -23.08% |
SCG | Scentre Group | $2.71 | Morgan Stanley | 2.90 | 3.18 | -8.81% |
SCP | Shopping Centres Australasia Property | $2.78 | Morgan Stanley | 2.75 | 3.10 | -11.29% |
SGP | Stockland | $3.69 | Morgan Stanley | 4.75 | 5.05 | -5.94% |
TAH | Tabcorp Holdings | $1.09 | Macquarie | 1.20 | 1.05 | 14.29% |
Ord Minnett | 1.15 | 1.10 | 4.55% | |||
TRS | Reject Shop | $3.45 | Morgan Stanley | 5.00 | 9.50 | -47.37% |
TUA | Tuas | $1.16 | Morgan Stanley | 1.65 | 2.20 | -25.00% |
VCX | Vicinity Centres | $1.93 | Morgan Stanley | 1.80 | 1.82 | -1.10% |
WPR | Waypoint REIT | $2.34 | Morgan Stanley | 2.20 | 2.70 | -18.52% |
Summaries
ABY | Adore Beauty | Overweight - Morgan Stanley | Overnight Price $1.22 |
AGL | AGL Energy | Outperform - Credit Suisse | Overnight Price $8.55 |
AIA | Auckland International Airport | Outperform - Macquarie | Overnight Price $6.70 |
AMC | Amcor | Buy - UBS | Overnight Price $17.92 |
ARF | Arena REIT | Equal-weight - Morgan Stanley | Overnight Price $4.51 |
AX1 | Accent Group | Overweight - Morgan Stanley | Overnight Price $1.30 |
BBN | Baby Bunting | Overweight - Morgan Stanley | Overnight Price $4.25 |
BHP | BHP Group | Outperform - Macquarie | Overnight Price $42.98 |
BWP | BWP Trust | Underweight - Morgan Stanley | Overnight Price $4.13 |
BWX | BWX | Downgrade to Neutral from Buy - Citi | Overnight Price $0.70 |
Outperform - Macquarie | Overnight Price $0.70 | ||
CAR | Carsales | Hold - Morgans | Overnight Price $20.76 |
CHC | Charter Hall | Equal-weight - Morgan Stanley | Overnight Price $11.71 |
CIP | Centuria Industrial REIT | Downgrade to Equal-weight from Overweight - Morgan Stanley | Overnight Price $3.03 |
CKF | Collins Foods | Outperform - Macquarie | Overnight Price $9.97 |
Upgrade to Add from Hold - Morgans | Overnight Price $9.97 | ||
Neutral - UBS | Overnight Price $9.97 | ||
CLW | Charter Hall Long WALE REIT | Downgrade to Equal-weight from Overweight - Morgan Stanley | Overnight Price $4.64 |
CNI | Centuria Capital | Overweight - Morgan Stanley | Overnight Price $1.99 |
COE | Cooper Energy | Neutral - Macquarie | Overnight Price $0.25 |
COF | Centuria Office REIT | Equal-weight - Morgan Stanley | Overnight Price $1.84 |
CPU | Computershare | Outperform - Credit Suisse | Overnight Price $24.45 |
CQR | Charter Hall Retail REIT | Underweight - Morgan Stanley | Overnight Price $4.04 |
CTD | Corporate Travel Management | Overweight - Morgan Stanley | Overnight Price $18.89 |
DXS | Dexus | Overweight - Morgan Stanley | Overnight Price $9.50 |
ELO | Elmo Software | Overweight - Morgan Stanley | Overnight Price $2.24 |
EVN | Evolution Mining | Buy - UBS | Overnight Price $2.58 |
GMG | Goodman Group | Overweight - Morgan Stanley | Overnight Price $18.99 |
GPT | GPT Group | Downgrade to Underweight from Equal-weight - Morgan Stanley | Overnight Price $4.59 |
HCW | HealthCo Healthcare & Wellness REIT | Downgrade to Equal-weight from Overweight - Morgan Stanley | Overnight Price $1.54 |
IVC | InvoCare | Equal-weight - Morgan Stanley | Overnight Price $10.69 |
JMS | Jupiter Mines | Outperform - Macquarie | Overnight Price $0.20 |
KMD | KMD Brands | Overweight - Morgan Stanley | Overnight Price $1.05 |
LFG | Liberty Financial | Downgrade to Neutral from Outperform - Credit Suisse | Overnight Price $4.30 |
LLC | Lendlease Group | Equal-weight - Morgan Stanley | Overnight Price $9.32 |
MGR | Mirvac Group | Equal-weight - Morgan Stanley | Overnight Price $2.12 |
MMS | McMillan Shakespeare | Overweight - Morgan Stanley | Overnight Price $9.74 |
NSR | National Storage REIT | Downgrade to Underweight from Equal-weight - Morgan Stanley | Overnight Price $2.32 |
NST | Northern Star Resources | Buy - Citi | Overnight Price $7.45 |
Outperform - Credit Suisse | Overnight Price $7.45 | ||
Outperform - Macquarie | Overnight Price $7.45 | ||
ORG | Origin Energy | Neutral - Credit Suisse | Overnight Price $5.93 |
PPM | Pepper Money | Outperform - Credit Suisse | Overnight Price $1.32 |
PWR | Peter Warren Automotive | Overweight - Morgan Stanley | Overnight Price $2.20 |
RBL | Redbubble | Equal-weight - Morgan Stanley | Overnight Price $0.92 |
SCG | Scentre Group | Equal-weight - Morgan Stanley | Overnight Price $2.73 |
SCP | Shopping Centres Australasia Property | Equal-weight - Morgan Stanley | Overnight Price $2.93 |
SGP | Stockland | Overweight - Morgan Stanley | Overnight Price $3.94 |
TAH | Tabcorp Holdings | Outperform - Credit Suisse | Overnight Price $1.08 |
Neutral - Macquarie | Overnight Price $1.08 | ||
Hold - Ord Minnett | Overnight Price $1.08 | ||
TGR | Tassal Group | Buy - UBS | Overnight Price $4.61 |
TRS | Reject Shop | Overweight - Morgan Stanley | Overnight Price $3.53 |
TUA | Tuas | Overweight - Morgan Stanley | Overnight Price $1.19 |
VCX | Vicinity Centres | Underweight - Morgan Stanley | Overnight Price $1.92 |
WPR | Waypoint REIT | Underweight - Morgan Stanley | Overnight Price $2.42 |
RATING SUMMARY
Rating | No. Of Recommendations |
1. Buy | 30 |
3. Hold | 20 |
5. Sell | 6 |
Wednesday 29 June 2022
Access Broker Call Report Archives here
Disclaimer:
The content of this information does in no way reflect the opinions of
FNArena, or of its journalists. In fact we don't have any opinion about
the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe
and comment on. By doing so we believe we provide intelligent investors
with a valuable tool that helps them in making up their own minds, reading
market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not
constitute an offer to sell or a solicitation to buy any security or other
financial instrument. FNArena employs very experienced journalists who
base their work on information believed to be reliable and accurate, though
no guarantee is given that the daily report is accurate or complete. Investors
should contact their personal adviser before making any investment decision.
Latest News
1 |
Monthly Listed Investment Trust Report – Oct 202412:00 PM - Australia |
2 |
The Case For Charter Hall11:30 AM - Australia |
3 |
Australian Listed Real Estate Tables – 07-10-202411:00 AM - Weekly Reports |
4 |
Australian Banks: When The End Of The Trend?10:38 AM - Feature Stories |
5 |
Weekly Ratings, Targets, Forecast Changes – 04-10-2410:00 AM - Weekly Reports |